Race and hormone receptor-positive breast cancer outcomes in a randomized chemotherapy trial.

Abstract

Factors other than disparities in care or aggressive disease contribute to increased recurrence in black women with hormone receptor-positive breast cancer.

Full Text

• DOI - Journal of the National Cancer Institute (DOI)
• Swets Information Services - full-text online
• Ovid Technologies, Inc. - full-text online
• OhioLINK Electronic Journal Center - full-text online
• HighWire Press - full-text online
• EBSCO - full-text online

Subjects

• Adult
• African Americans
• Aged
• Aged, 80 and over
• Antineoplastic Combined Chemotherapy Protocols
• Breast Neoplasms
• Chemotherapy, Adjuvant
• Clinical Trials, Phase III as Topic
• Disease-Free Survival
• Female
• Healthcare Disparities
• Humans
• Kaplan-Meier Estimate
• Mastectomy
• Middle Aged
• Multivariate Analysis
• Neoplasm Recurrence, Local
• Neoplasm Staging
• Odds Ratio
• Randomized Controlled Trials as Topic
• Receptor, erbB-2
• Receptors, Estrogen
• Receptors, Progesterone
• Retrospective Studies
• Risk Factors
• Survival Analysis
• Taxoids
• Treatment Outcome
• Tumor Markers, Biological
• United States

Similar articles

• Hormone receptor expression in breast cancer: postanalytical issues. (2013-03-22)
• mTOR inhibitors in advanced breast cancer: Ready for prime time? (2013-04-01)
• Predictive value of Ki67 for adjuvant chemotherapy in node-negative, hormone receptor-positive breast cancer. (2013-04-17)
• How relevant is hormone receptor status in the context of outcome to HER2-positive breast cancer? (2013-01-14)
• Conversion of epidermal growth factor receptor 2 and hormone receptor expression in breast cancer metastases to the brain. (2012-08-16)
• A case of male invasive breast carcinoma presenting as a non-healing wound. (2013-02-15)
• A review of the treatment of endocrine responsive metastatic breast cancer in postmenopausal women. (2012-07-25)
• Poor outcome of hormone receptor-positive breast cancer at very young age is due to tamoxifen resistance: nationwide survival data in Korea--a report from the Korean Breast Cancer Society. (2007-06-11)
• Integration of ERα-PELP1-HER2 signaling by LSD1 (KDM1A/AOF2) offers combinatorial therapeutic opportunities to circumventing hormone resistance in breast cancer. (2012-09-17)
• Hormone-sensing cells require Wip1 for paracrine stimulation in normal and premalignant mammary epithelium. (2013-01-31)

Authors

• Joseph A Sparano
• Molin Wang
• Fengmin Zhao
• Vered Stearns
• Silvana Martino
• Jennifer A Ligibel
• Edith A Perez
• Tom Saphner
• Antonio C Wolff
• George W Sledge
• William C Wood
• Nancy E Davidson

Publication date

2012-03-07

Journal

Journal topics

• Neoplasms

Language

Eng.

Copyright

Journal of the National Cancer Institute

Albert Einstein College of Medicine, Montefiore Medical Center-Weiler Division, 1825 Eastchester Rd, 2S-Rm 47, Bronx, NY 10461, USA. jsparano [at] montefiore.org

Release reference

J Natl Cancer Inst. 2012 Mar;104(5):406-14

Related books

• Books of African Americans
• Books of Antineoplastic Combined Chemotherapy Protocols
• Books of Breast Neoplasms
• Books of Chemotherapy, Adjuvant
• Books of Clinical Trials, Phase III as Topic
• Books of Disease-Free Survival
• Books of Healthcare Disparities
• Books of Kaplan-Meier Estimate
• Books of Mastectomy
• Books of Multivariate Analysis
• Books of Neoplasm Recurrence, Local
• Books of Neoplasm Staging
• Books of Neoplasms
• Books of Odds Ratio
• Books of Randomized Controlled Trials as Topic
• Books of Receptor, erbB-2
• Books of Receptors, Estrogen
• Books of Receptors, Progesterone
• Books of Retrospective Studies
• Books of Risk Factors
• Books of Survival Analysis
• Books of Taxoids
• Books of Treatment Outcome
• Books of Tumor Markers, Biological
• Books of United States